胆囊癌发病机制及外科治疗的研究进展

张复波; 张雅敏

doi:10.3969/j.issn.1001-5256.2018.05.045

胆囊癌发病机制及外科治疗的研究进展

DOI: 10.3969/j.issn.1001-5256.2018.05.045

天津市第一中心医院肝胆外科

详细信息

中图分类号: R735.8
计量
- 文章访问数: 2089
- HTML全文浏览量: 16
- PDF下载量: 474
- 被引次数: 0
出版历程
- 出版日期: 2018-05-20

Research advances in the pathogenesis and surgical treatment of gallbladder carcinoma

Department of Hepatobiliary Surgery, Tianjin First Central Hospital, Tianjin 300192, China

摘要

摘要:
胆囊癌(GBC)在临床上常易被一些良性疾病所掩盖而发生意外胆囊癌(IGBC)。在病因方面,胆囊结石的长期刺激、>1 cm的胆囊息肉、胆囊腺瘤及胆囊腺肌症等与GBC的关系密切。在分子生物学机制家方面,长链非编码RNA、微小RNA、表面生长因子受体以及一些膜蛋白等均参与GBC的发生发展,有望为临床提供一定的参考价值。GBC的术中、术后的外科处理至关重要,关乎患者的生存期。在术中高度怀疑或已证实GBC的患者中,充分评估病情,应及早中转开腹,避免二次手术。术后病理检查发现的IGBC,应尽早行二次手术,以免肿瘤进展和扩散。
- 胆囊肿瘤 /
- 基因表达调控,肿瘤 /
- 外科手术 /
- 综述
Abstract:
Gallbladder carcinoma ( GBC) is often obscured by some benign diseases in clinical practice and thus unsuspected GBC tends to occur. As for etiology, long-term stimulation by gallstones, gallbladder polyps larger than 1 cm, gallbladder adenoma, and adenomyomatosis of the gallbladder are closely associated with GBC. In the aspect of molecular biology, long non-coding RNA, microRNA, surface growth factor receptor, and some membrane proteins are involved in the development and progression of GBC, which may provide a reference for clinical practice. It is of great importance to perform intraoperative and postoperative surgical management of GBC, which is related to patients' survival. Patients with highly suspected or proven GBC should be converted to open surgery after disease assessment, in order to avoid reoperation. Reoperation should be performed for patients with unsuspected GBC found by postoperative pathological examination, in order to avoid tumor progression and metastasis.
- gallbladder neoplasms /
- gene expression regulation, neoplastic /
- surgical procedures, operative /
- review

HTML全文

参考文献(36)

[1]BOUTROS C, GARY M, BALDWIN K, et al.Gallbladder cancer:past, present and an uncertain future[J].Surg Oncol, 2012, 21 (4) :e183-e191.

[2]APODACA-RUEDA M, CAZZO E, DE-CARVALHO RB, et al.Prevalence of gallbladder cancer In patients submitted to cholecystectomy:experience of the University Hospital, Faculty of Medical Sciences, State University of Campinas-UNICAMP[J].Rev Col Bras Cir, 2017, 44 (3) :252-256.

[3]SHI JS, ZHENG JB, MA M, et al.Perplexities and considerations indiagnosis and treatment of gallbladder cancer[J].J Hepatopancreatobiliary Surg, 2016, 28 (1) :1-4. (in Chinese) 石景森, 郑见宝, 马茂, 等.胆囊癌诊治中的困惑与思考[J].肝胆胰外科杂志, 2016, 28 (1) :1-4.

[4]TOMIC'DV, MARKOVIC'AR, ALEMPIJEVIC'TM, et al.Ultrasound diagnosis of gallbladder polyps[J].Acta Chir Iugosl, 2011, 58 (4) :31-35.

[5]KASLE D, RAHNEMAI-AZAR AA, BIBI S, et al.Carcinoma in situ in a 7 mm gallbladder polyp:Time to change current practice?[J].World J Gastrointest Endosc, 2015, 7 (9) :912-915.

[6]ZHANG ZX, YIN WH, ZHU ZY, et al.Gallbladder adenoma and adenoma carcinogenesis:a report of 12 cases and a comprehensive analysis of 76 cases in China[J].Chin J Surg, 1994, 32 (7) :400-402. (in Chinese) 张兆祥, 尹为华, 朱忠尧, 等.胆囊腺瘤和腺瘤癌变:12例报告和国内76例综合分析[J].中华外科杂志, 1994, 32 (7) :400-402.

[7]ZHANG C, CHEN L, YU RS.CT manifestations of gallbladder adenoma and partial malignant transformation[J].J Med Imaging, 2016, 26 (9) :1710-1713. (in Chinese) 张超, 陈璐, 余日胜.胆囊腺瘤及局部癌变的CT表现[J].医学影像学杂志, 2016, 26 (9) :1710-1713.

[8]WANG JM, TIAN L, AO QL, et al.New recognition of the relationship between gallbladder benign lesions and gallbladder cancer[J].Chin J Dig Surg, 2017, 16 (4) :363-367. (in Chinese) 王剑明, 田礼, 敖启林, 等.胆囊良性病变与胆囊癌关系的新认识[J].中华消化外科杂志, 2017, 16 (4) :363-367.

[9]WEN Z, SI A, YANG J, et al.Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma[J].HPB (Oxford) , 2017, 19 (11) :951-956.

[10]CAI Q, WANG Z, WANG S, et al.Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelialmesenchymal transition by regulating HIF-1alpha via miR-138[J].Open Biol, 2017, 7 (1) :160247.

[11]LI D, LIU X, ZHOU J, et al.LncRNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of ERK and YB-1 to enhance hepatocarcinogenesis[J].Hepatology, 2017, 65 (5) :1612-1627.

[12]MA MZ, ZHANG Y, WENG MZ, et al.Long noncoding RNA GCASPC, a target of miR-17-3p, negatively regulates pyruvate carboxylase-dependent cell proliferation in gallbladder cancer[J].Cancer Res, 2016, 76 (18) :5361-5371.

[13]WANG SH, YANG Y, WU XC, et al.Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression[J].Cancer Lett, 2016, 380 (1) :122-133.

[14]CHANG Y, LIU C, YANG J, et al.MiR-20a triggers metastasis of gallbladder carcinoma[J].J Hepatol, 2013, 59 (3) :518-527.

[15]KONO H, NAKAMURA M, OHTSUKA T, et al.High expression of microRNA-1 55 is associated with the aggressive malignant behavior of gallbladder carcinoma[J].Oncol Rep, 2013, 30 (1) :17-24.

[16]MYDLARZ WK, HENNESSEY PT, CALIFANO JA.Advances and perspectives in the molecular diagnosis of head and neck cancer[J].Expert Opin Med Diagn, 2010, 4 (1) :53-65.

[17]TEBBUTT N, PEDERSEN MW, JOHNS TG.Targeting the ERBB family in cancer:couples therapy[J].Nat Rev Cancer, 2013, 13 (9) :663-673.

[18]LI M, ZHANG Z, LI X, et al.Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the Erb B pathway[J].Nat Genet, 2014, 46 (8) :872-876.

[19]PAIS-COSTA SR, FARAH JF, ARTIGIANI-NETO R, et al.Evaluation of P53, E-cadherin, Cox-2, and EGFR protein immunoexpression on prognostic of resected gallbladder carcinoma[J].Arq Bras Cir Dig, 2014, 27 (2) :126-132.

[20]BUFTE JM, WAUGH E, MENESES M, et al.Incidental gallbladder cancer:analysis of surgical findings and survival[J].Surg Oncol, 2010, 102 (6) :620-625.

[21]DOU KF, AN JZ.Surgical treatment of accidental gallbladder cancer[J].Chin J Pract Surg, 2011, 31 (3) :219-220. (in Chinese) 窦科峰, 安家泽.意外胆囊癌的外科处理[J].中国实用外科杂志, 2011, 31 (3) :219-220.

[22]WEMBERG JA, LUCARELLI DD.Gallbladder cancer[J].Surg clin Nonh Am, 2014, 94 (2) :343-360.

[23]BENSON AB 3rd, D'ANGELICA MI, ABRAMS TA, et al.Hepatobi Iiary cancer, version 2.2014[J].J Natl Compr Canc Netw, 2014, 12 (8) :1152-1182.

[24]CREASY JM, GOLDMAN DA, DUDEJA V, et al.Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma:surgical and survival outcomes[J].J Am Coll Surg, 2017, 224 (5) :906-916.

[25]KASUMOVA GG, TABATABAIE O, NAJARIAN RM, et al.Surgical management of gallbladder cancer:simple versus extended cholecystectomy and the role of adjuvant therapy[J].Ann Surg, 2017, 266 (4) :625-631.

[26]LEE SE, JANG JY, LIM CS, et al.Systematic review on the surgical treatment for T1 gallbladder cancer[J].World J Gastmenterol, 2011, 17 (2) :174-180.

[27]YU Y, JIANG XQ.Surgical staging treatment of gallbladder carcinoma[J/CD].Chin J Hepatic Surg:Electronic Edition, 2012, 1 (3) :151-156. (in Chinese) 于勇, 姜小清.胆囊癌的外科分期治疗[J/C].中华肝脏外科手术学电子杂志, 2012, 1 (3) :151-156.

[28]ISAMBERT M, LEUX C, MTAIRIE S, et al.Incidentally-discovered gallbladder cancer:When, why and which reoperation?[J]J Visc Surg, 2011, 148 (2) :e77-e84.

[29]JAYARAMAN S, IARNAGIN WR.Management of gallbladder cancer[J].Gastroenterol Clin North Am, 2010, 39 (2) :331-342.

[30]MEKEEL KL, HEMMING AW.Surgical management of gallbladder carcinoma:a review[J].J Gastrointest Surg, 2007, 11 (9) :1188-1193.

[31]KOHYA N, MIYAZAKI K.Hepatectomy of segment 4a and 5 combined wifh extra-hepatic bile duct resection for T2 and T3 gallb Iadder carcinoma[J].J Surg Oncol, 2008, 97 (6) :498-502.

[32]ARAIDA T, HIGUCHI R, HAMANO M, et al.Should the extrahepalic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma?Results of a Japanese Society of Biliary Surgery Survey:a multicenter study[J].Surg Today, 2009, 39 (9) :770-779.

[33]Biliary Surgery Group of Surgery Branch of Chinese Medical Association.Guideline for the diagnosis and treatment of gallbladder carcinoma (2015 edition) [J].J Clin Hepatol, 2016, 32 (3) :411-419. (in Chinese) 中华医学会外科学分会胆道外科学组.胆囊癌诊断和治疗指南 (2015版) [J].临床肝胆病杂志, 2016, 32 (3) :411-419.

[34]BARAKAT J, DUNKELBERG JC, MA TY.Changing patterns of gallbladder carcinoma in New Mexico[J].Cancer, 2006, 106 (2) :434-440.

[35]SAKATA J, KOBAYASHI T, OHASHI T, et al.Prognostic heterogeneity of the seventh edition of UICC Stage III gallbladder carcinoma:Which patients benefit from surgical resection?[J].Eur J Surg Oncol, 2017, 43 (4) :780-787.

[36]SUO T, LIU HB.Surgical treatment for unsuspected gallbladder carcinoma[J/CD].Chin J Hepatic Surg:Electronic Edition, 2016, 5 (4) :206-208. (in Chinese) 锁涛, 刘厚宝.意外胆囊癌的外科治疗[J/CD].中华肝脏外科手术学电子杂志, 2016, 5 (4) :206-208.

施引文献

资源附件(0)

访问统计